2 results
Approved WMORecruiting
The main objective of this pilot study is to determine PKI concentration in tumor tissue after approximately two weeks of treatment.
Approved WMORecruiting
The objective of the study is to assess the long-term safety and efficacy of intravenous ATB200 co-administration with oral AT2221 in adult subjects with late-onset Pompe disease.